| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.07 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.092 | 0.07 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.092 | 0.07 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.07 |